Home / Market News / $INGN

$INGN news and market catalysts

The 2 most recent market catalysts affecting $INGN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

2 catalysts 1 high impact 1 bullish 1 bearish Medical Devices

Aug 6, 2026 Corporate Catalyst Bearish Impact 75

Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est

Inogen (INGN) has lowered its FY2026 sales guidance from an initial range of $366.0 million-$373.0 million to a new range of $355.0 million-$361.0 million. This revised outlook is …

Aug 6, 2026 Corporate Catalyst Bullish Impact 92

Inogen Q2 Sales $95.084M Miss $95.233M Estimate

Inogen's Q2 sales of $95.084 million missed analyst consensus by a narrow margin of 0.16%. While the miss is small, any deviation from expectations, especially on the downside for …

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.